On this page
IQSEC2
IQ motif and Sec7 domain ArfGEF 2
IQSEC2 encodes a protein that regulates intracellular signalling in neurons, with pathogenic variants linked to neurodevelopmental conditions. The IQSEC2 gene produces a guanine nucleotide exchange factor critical for neuronal function and synaptic plasticity.
IQSEC2 is located on the short (p) arm of chromosome X, at band Xp11.22. Arm ratio per GRCh38 - banding schematic.
Explore chromosome X in the library →Overview
IQSEC2 encodes IQ motif and Sec7 domain ArfGEF 2, a member of the guanine nucleotide exchange factor (GEF) family. This protein plays a crucial role in neuronal signalling by activating small GTPases that regulate membrane trafficking and synaptic function. Located on the X chromosome, IQSEC2 follows an X-linked inheritance pattern, meaning pathogenic variants typically cause more severe effects in males who carry only one copy of the gene. Research has established that disruption of IQSEC2 function impairs neuronal development and synaptic plasticity, contributing to a range of neurodevelopmental outcomes. The gene is recognised within UK clinical genomics pathways for assessment of intellectual disability and epilepsy.
What the gene does
The IQSEC2 protein functions as a guanine nucleotide exchange factor, catalysing the exchange of GDP for GTP on ADP-ribosylation factor (Arf) family GTPases. This activation step is essential for regulating vesicle trafficking, receptor recycling, and organisation of the neuronal cytoskeleton. The protein's SEC7 domain mediates the core GEF activity, whilst the IQ motif enables calcium-dependent regulation through calmodulin binding, allowing neuronal activity to modulate signalling dynamics.
Within neurons, IQSEC2 localises to dendritic spines and participates in synaptic plasticity mechanisms. The protein influences AMPA receptor trafficking at excitatory synapses, a process fundamental to learning and memory consolidation. Through its regulation of Arf GTPases, IQSEC2 coordinates membrane remodelling events required for spine morphology changes during synaptic strengthening. Disruption of these activities compromises the neuron's ability to adapt synaptic connections in response to experience, affecting cognitive development and neuronal network function.
Video: Genetics 101
Chromosome location
IQSEC2 is located on the short arm of the X chromosome at position p11.22 (Xp11.22). This chromosomal region contains numerous genes involved in neurological function, and its position on the X chromosome determines the gene's inheritance characteristics. The gene spans approximately 400 kilobases of genomic DNA and contains multiple exons that are transcribed and spliced to produce the mature messenger RNA template for protein synthesis.
Protein structure
The IQSEC2 protein (longest isoform, 1,488 amino acids) contains several functionally important domains. Near the amino terminus, a coiled coil region (amino acids 23-74) likely mediates protein-protein interactions. The IQ domain (amino acids 347-376) binds calmodulin in a calcium-dependent manner, providing regulatory input from neuronal activity. The SEC7 domain (amino acids 746-939) represents the catalytic core responsible for guanine nucleotide exchange activity on Arf GTPases.
A notable feature of IQSEC2's architecture is the presence of extensive disordered regions distributed throughout the sequence, including stretches spanning amino acids 50-88, 107-147, 161-290, 479-578, 623-726, 1091-1259, and 1271-1488. These intrinsically disordered regions often facilitate dynamic interactions with multiple binding partners and allow conformational flexibility important for regulatory functions in complex signalling networks.
Key variants
Pathogenic variants in IQSEC2 encompass loss-of-function changes including nonsense variants, frameshifts, and deletions, as well as missense variants affecting critical functional domains. The majority of reported pathogenic variants cluster within or near the SEC7 and IQ domains, disrupting either the core catalytic activity or calcium-dependent regulation. Because IQSEC2 follows X-linked inheritance, males carrying a single pathogenic variant typically manifest more pronounced phenotypic features, whilst heterozygous females may show variable expression depending on X-inactivation patterns.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.1405_1406del | p.Lys469fs | Pathogenic | ★★☆☆ | Intellectual disability |
c.1586_1587del | p.Pro529fs | Pathogenic | ★★☆☆ | Intellectual disability, X-linked 1 |
c.1591C>T | p.Arg531Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Intellectual disability |
c.1637G>A | p.Trp546Ter | Pathogenic | ★★☆☆ | Intellectual disability, X-linked 1 |
c.1676del | p.Pro559fs | Pathogenic | ★★☆☆ | not provided |
c.2272C>T | p.Arg758Ter | Pathogenic | ★★☆☆ | not provided |
c.2459+21C>T | - | Pathogenic | ★★☆☆ | Intellectual disability, X-linked 1 |
c.2507C>T | p.Ala836Val | Pathogenic/Likely pathogenic | ★★☆☆ | not provided |
c.2563C>T | p.Arg855Ter | Pathogenic | ★★☆☆ | Intellectual disability, X-linked 1 |
c.2710C>T | p.Arg904Ter | Pathogenic | ★★☆☆ | Intellectual disability, X-linked 1 |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in IQSEC2 are primarily associated with neurodevelopmental disorders characterised by intellectual disability and epilepsy. Affected males typically present with moderate to severe intellectual disability, often accompanied by seizures that may begin in infancy or early childhood. Additional features can include delayed motor milestones, behavioural difficulties, and some individuals show autism spectrum characteristics. Heterozygous females may exhibit milder cognitive impairment or remain largely asymptomatic, though symptomatic females have been documented, reflecting the influence of X-inactivation patterns on phenotypic expression.
No disease links recorded for this gene in our reference set.
Inheritance pattern
Conditions caused by pathogenic IQSEC2 variants typically follow x-linked inheritance.
X-linked recessive: sons of a carrier mother have a 50% chance of being affected. Daughters have a 50% chance of being carriers.
UK clinical status
Within the NHS Genomic Medicine Service, IQSEC2 appears on multiple clinical gene panels. It holds green classification (indicating high-quality evidence for disease causation) on the Developmental Disorders Genotype-to-Phenotype (DDG2P) panel, the Early Onset or Syndromic Epilepsy panel (R59), and the Intellectual Disability panel (R29). These designations reflect the established clinical validity of IQSEC2 variants in causing neurodevelopmental presentations and support its inclusion in diagnostic genomic testing pathways for individuals with unexplained intellectual disability or epilepsy, particularly when features suggest X-linked inheritance.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Diet & lifestyle considerations
No specific lifestyle modifications have established evidence for IQSEC2-related conditions. Management focuses on symptom-specific interventions tailored to each individual's neurological and developmental needs, guided by specialist multidisciplinary teams.
Supplement considerations
No dietary supplements have established evidence for modifying the course of IQSEC2-related neurodevelopmental conditions. Treatment approaches centre on addressing specific symptoms such as seizure management and developmental support rather than supplementation.
Frequently asked questions
How is IQSEC2-related neurodevelopmental disorder inherited?
IQSEC2 follows X-linked inheritance. Males who inherit a pathogenic variant typically show more severe features because they have only one X chromosome. Females carrying a pathogenic variant may be mildly affected or asymptomatic, depending on random X-inactivation patterns, though some manifest significant symptoms.
Why does IQSEC2 primarily affect neurological function?
The IQSEC2 protein regulates synaptic signalling and receptor trafficking specifically required for neuronal plasticity. Its role in modulating AMPA receptor dynamics at excitatory synapses is particularly important for learning and memory processes, explaining why disruption manifests predominantly as intellectual disability and seizures.
Can females with an IQSEC2 variant have symptoms?
Yes, although X-linked conditions typically affect males more severely, females carrying IQSEC2 pathogenic variants can be symptomatic. The pattern of X-inactivation in each female determines the proportion of cells expressing the variant allele, leading to variable clinical presentations ranging from mild learning difficulties to more significant intellectual disability.